• Explore /
  • Poster
  • / Clinical impact of primary tumor location in patients with metastatic colorectal cancer (mCRC) treated with regorafenib or trifluridine/tipiracil as later-line.

Clinical impact of primary tumor location in patients with metastatic colorectal cancer (mCRC) treated with regorafenib or trifluridine/tipiracil as later-line.

Abstract Poster

Authors

null

Hiromichi Nakajima

Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan

Hiromichi Nakajima , Shota Fukuoka , Toshikazu Moriwaki , Toshiki Masuishi , Atsuo Takashima , Yosuke Kumekawa , Takeshi Kajiwara , Kentaro Yamazaki , Masato Komoda , Akitaka Makiyama , Tadamichi Denda , Yukimasa Hatachi , Takeshi Suto , Naotoshi Sugimoto , Masanobu Enomoto , Toshiaki Ishikawa , Tomomi Kashiwada , Eiji Oki , Masahiko Gosho , Yasuhiro Shimada

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Anal and Colorectal Cancer

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 105)

Abstract #

105

Poster Bd #

E13

Abstract Disclosures

Similar Posters

First Author: Keigo Chida

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Real-world treatment patterns and unmet need in patients with previously treated metastatic colorectal cancer that is not MSI-H or dMMR.

Real-world treatment patterns and unmet need in patients with previously treated metastatic colorectal cancer that is not MSI-H or dMMR.

First Author: Kaushal Desai

First Author: Seiichiro Mitani

First Author: Arvind Dasari